The highs and lows of translational drug development: antibody-mediated inhibition of ADAMTS-5 for osteoarthritis disease modification
| Autor: | Larkin, J., Lohr, T., Elefante, L., Shearin, J., Matico, R., Su, J-L., Xue, Y., Liu, F., Rossman, E.I., Renninger, J., Wu, X., Abberley, L., Miller, R.E., Foulcer, S., Chaudhary, K.W., Genell, C., Murphy, D., Tran, P.B., Apte, S., Malfait, A-M., Maier, C.C., Matheny, C.J. |
|---|---|
| Zdroj: | In Osteoarthritis and Cartilage April 2014 22 Supplement:S483-S484 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect